These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

68 related items for PubMed ID: 8573174

  • 1. Angiotensin converting enzyme inhibitor normalizes vascular natriuretic peptide type A receptor gene expression via bradykinin-dependent mechanism in hypertensive rats.
    Yoshimoto T, Naruse K, Shionoya K, Tanaka M, Seki T, Hagiwara H, Hirose S, Kuen LS, Demura H, Naruse M, Muraki T.
    Biochem Biophys Res Commun; 1996 Jan 05; 218(1):50-3. PubMed ID: 8573174
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Bradykinin may not be involved in improvement of insulin resistance by angiotensin converting enzyme inhibitor.
    Chen S, Kashiwabara H, Kosegawa I, Ishii J, Katayama S.
    Clin Exp Hypertens; 1996 Jul 05; 18(5):625-36. PubMed ID: 8781750
    [Abstract] [Full Text] [Related]

  • 7. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V, Rigamonti A, Fioretti S, Bonomo S, Manfredi B, Ferrario P, Bianchi M, Berti F, Muller EE, Rossoni G.
    Eur J Pharmacol; 2005 Jun 15; 516(3):253-9. PubMed ID: 15963975
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. An angiotensin II receptor antagonist attenuates left ventricular dilatation after myocardial infarction in the hypertensive rat.
    Nishikimi T, Yamagishi H, Takeuchi K, Takeda T.
    Cardiovasc Res; 1995 Jun 15; 29(6):856-61. PubMed ID: 7656290
    [Abstract] [Full Text] [Related]

  • 12. Effect of an angiotensin II receptor antagonist, TCV-116, on cardiac hypertrophy and coronary circulation in spontaneously hypertensive rats.
    Takeda K, Fujita H, Nakamura K, Uchida A, Tanaka M, Itoh H, Nakata T, Sasaki S, Nakagawa M.
    Blood Press Suppl; 1994 Jun 15; 5():94-8. PubMed ID: 7889211
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Involvement of angiotensin II in cardiovascular and renal injury: effects of an AT1-receptor antagonist on gene expression and the cellular phenotype.
    Kim S, Iwao H.
    J Hypertens Suppl; 1997 Dec 15; 15(6):S3-7. PubMed ID: 9493120
    [Abstract] [Full Text] [Related]

  • 16. Gene expression of the type-1 angiotensin II receptor in rat adrenal gland.
    Wakamiya R, Kohara K, Hiwada K.
    Blood Press Suppl; 1994 Dec 15; 5():109-12. PubMed ID: 7889191
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The role of activated vascular angiotensin II generation in vascular hypertrophy in one-kidney, one clip hypertensive rats.
    Yu H, Rakugi H, Higaki J, Morishita R, Mikami H, Ogihara T.
    J Hypertens; 1993 Dec 15; 11(12):1347-55. PubMed ID: 8133017
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.